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KLEINE-LEVIN SYNDROME
Interface between neurology and psychiatry
Luís Pereira Justo1, Helena Maria Calil2, Sílvia A. Prado-Bolognani3, Mauro Muszkat4
ABSTRACT -  We report the first episode of Kleine-Levin (KLS) syndrome in a 17-year-old male. The illness
onset, clinical features, neuropsychological evaluation and polysomnographic recording are described.
Typical symptoms hypersomnia, hyperphagia and sexual disinhibition were observed besides behavioral
disturbances, polysonographic and neuropsychological alterations. Behavioral disturbances similar to a
manic episode including psychotic symptoms were relevant. The pharmacologic treatment included lithi-
um, methylphenidate and risperidone. The introduction of risperidone aimed the control of psychotic
symptoms and the persistent manifestations of hypersexuality after sleepness control and to the best of
our knowledge there are no other report regarding risperidone use for KLS in the literature.
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Síndrome de Kleine-Levin: interface entre neurologia e psiquiatria
RESUMO - Relatamos o primeiro episódio de síndrome de Kleine-Levin (SKL) num adolescente de 17 anos. São
descritos o modo de aparecimento da doença, achados clínicos, avaliação neuropsicológica e polissonogra-
fia. Foram observados sintomas típicos como hipersonolência, hiperfagia e desinibição sexual, e outras altera-
ções comportamentais, polissonográficas e neuropsicológicas. As alterações comportamentais assemelhadas
a um episódio de mania, incluindo sintomas psicóticos, foram relevantes. O tratamento farmacológico incluiu
lítio, metilfenidato e risperidona. A introdução de risperidona teve por objetivo o controle dos sintomas
psicóticos e das persistentes manifestações da hipersexualidade, que permaneceram após diminuição da
sonolência; não temos conhecimento de relatos anteriores, na literatura, de seu uso no tratamento da SKL.
PALAVRAS-CHAVE: Kleine-Levin, neuropsicologia, polissonografia, risperidona, transtorno de sono.
The Kleine–Levin syndrome (KLS) is characterized
by episodes of recurrent hypersomnia, hyperphagia
or megaphagia and behavioral alterations, mainly
sexual disinhibition; the prognosis is benign, since
the episodes often decrease in frequency and inten-
sity with age, finally reaching spontaneous remis-
sion1,2. This syndrome has its typical onset during the
second decade of the patients’ life, and is more preva-
lent among men3. The diagnosis was first described
and formalized in the first half of 20th century4-6.
There were approximately 500 cases described all
over the world until the year 20007. A recent pub-
lished systematic review found 186 different cases
reported in 195 articles in Medline ranging from 1962
to 20048. This review shows that men were 68% of
the cases, the median age of onset was 15 years (ran-
ge 4-82 years, 81% during the second decade) and
the mean duration of syndrome was 8 years8.
We report the first episode of KLS in a young man.
CASE
A 17-years-old male student, had no history of previ-
ous behavioral alterations or illnesses, except for those that
are common in childhood; no use of alcohol or drugs and
without family history of mental illness. He perpetrated a
sexual attack on a stranger woman in a public place. Min-
utes later, he presented sleepiness and disorganized
thought. He was taken to a hospital and remained there
for 3 days. He went through several exams, among them
resonance imaging of the head and exam of cerebrospinal
fluid; all of them did not show any alterations. 
The behavioral alterations became more pronounced;
he was discharged from the hospital and referred to a psy-
chiatrist, with a provisional diagnosis of schizophreniform
disorder. Due to his excessive sleepiness (he slept approxi-
mately 21 hours a day on the first days), the psychiatrist re-
referred the patient to another neurologist, who put for-
ward the hypothesis of KLS. A polysomnography was car-
ried out and revealed a pattern of low voltage rhythm,
with reduced sleep latency and REM latency, and a reduc-
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tion of the elements characteristics of the sleep phases II ,
III and IV (Table 1).
When awake, he was irritable and had hypersexualized
behavior directed to women. His liquids intake was also re-
markable (polidypsia) and in a few days later he manifest-
ed hyperphagia. The psychiatric assessment revealed dis-
orientation regarding time, but not space, nor self, agita-
tion, pressured speech, discreet thought disorganization,
delusional ideation with grandiose and sometimes perse-
cutory content and auditory hallucinations. There were
outbursts of verbal aggressiveness. He would make occa-
sional references to his experiences as if they were the result
of some kind of health problem, suggesting some degree
of “awareness of illness”. Although there were variations
in the intensity and predominance of symptoms, his con-
dition remained almost the same for approximately 50 days
after beginning treatment. The disappearance of his symp-
toms was gradual, and when recovered the patient resumed
the same behavior he had before the onset of the syn-
drome, showing a quite adequate notion of having gone
through a period of behavioral alterations, with abundant
though unclear recollections of the sensations and situa-
tions he had experienced. He remarked he had lived that
period as if he was in a dream from which he could not
awake completely. Following the diagnosis of KLS, lithium
(600 mg initially, adjusted according to the blood level, to
900 mg/day, in order to reach 0.6 µMol/L) and methylphe-
nidate (10 mg/day in the first fortnight) were introduced.
In the 23rd day of treatment, when the patient had already
had a significant reduction of hypersomnia, the psychotic
symptoms, hyperfagia and hypersexuality began to prevail.
Then methylphenidate was interrupted and risperidone
was initiated (2 mg/day, later increased to 4 mg/day). A neu-
ropsychological evaluation was carried out two months after
the beginning of treatment, and its results are in Table 2.
The analysis revealed reduced attentional span, reduced
immediate retention for verbal and visual stimuli, but good
acquisition and retrieval capacities. The patient demon-
strated normal intellectual efficiency, with a significant dis-
crepancy between the verbal and executive functions, show-
ing satisfactory performance in tasks based on language
and abstract thinking. However he presented major diffi-
culties regarding motor-visual speed and precision, as well
as visuospatial planning strategies. The executive functions
evaluated by the Wisconsin test (6 categories were carried
out) showed satisfactory performance. After, he remained
stable for approximately 3 months the medication was grad-
ually reduced until its complete withdrawal. 
The patients signed the informed consent for this pub-
lication.
DISCUSSION
The KLS is a challenge to the physician, since its
causes are not yet clear, its symptoms are a mix of
manifestations of neurological illnesses and psychi-
atric disorders, and also because of the uncertainties
regarding its treatment. Although the psychiatric
symptoms associated to the KLS have been report-
ed9-12, they seem hardly understood.
This case illustrates the similarities between some
of the KLS symptoms and those of a manic state
which, in spite of being typical of bipolar disorder,
might also occur in several diseases. Such similarity
has been previously mentioned9. Additionally, it is
also noteworthy that the drug treatments most fre-
quently used to treat the KLS are the same used in
the treatment of bipolar disorder such as lithium.
The choice of risperidone among the antipsychotic
medications was due to the fact that it has a weak
sedative property, a small potential to produce extra-
pyramidal adverse reactions at low doses, and main-
ly because it quickly increases the levels of prolactin,
which seems to be associated to the reduction of the
libido and possibly to the control of manifestations
of hypersexuality (our patient had simultaneous
increase of prolactin and reduction of hypersexuali-
ty). To the best of our knowledge there are not re-
ports in the literature of the risperidone use in the
KLS treatment. The diagnosis of KLS is purely clini-
Table 1.  Polysomnographic measures during the state of hyper-
somnolence (range/normal).
Total time in bed (min) 387 (360-480)
Total sleep time (min) 370 (300-500)
Sleep efficiency (min) 99 (80-100)
Sleep latency (min) 01 (<20)
REM latency (min) 30 (65-120)
Stage I (%) 21 (2-9)
Stage II (%) 39 (40-60)
Stage III (%) 18 (10-30)
Stage IV (%) 03 ( 5-30)
REM  (%) 20 (10-30)
Table 2. Neuropsychological (Interictal Period).
Function (Test) Percentile/Score Conclusion
Verbal attention
(WMS)
9 Marked difficulty
Visual attention
/Coding (WAIS-R)
25 Moderate difficulty
Language (FAS) 80 Good performance
Vocabulary (WAIS-R) 50 Satisfactory
Verbal IQ (WAIS-R) 97 Verbal-execution
discrepancy 
Executive IQ (WAIS-R) 75 Moderate difficulty
Executive function
(WCST)
6 categories Good performance
WMS, Wechsler memory scale; WAIS-R, Wechsler adult intelligence scale-
revised; WCST, Wisconsin card sort test.
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cal, even though there is often suggestion of neuro-
logical and neurophysiologic abnormalities, leading
physicians to think of dysfunction in the diencephal-
ic areas, mainly in hypothalamus. Therefore, physi-
cians can observe polysomnographic alterations such
as a reduction of the REM sleep latency, REM laten-
cy and superficial sleep with a reduction of stages III
and IV, as were observed in this case. The neuropsy-
chological of him seems to corroborate the hypoth-
esis of integrity of prefrontal areas, since his execu-
tive functions were preserved. His visual-constructive
difficulties, the discrepancy between his non-verbal
intellectual functioning and use of language, on the
other hand, could be related to the involvement of
associative areas of the no dominant hemisphere,
important for the balance and modulation of the
functions related to the attentional control, the affec-
tive/emotional modulation and the impulses control,
including the inhibitory sexual behavior. The clinical
polymorphism and the significance of the psychiatric
manifestations during the KLS episodes highlight the
need for neurologists and psychiatrists to work to-
gether when taking care of these patients.
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